PRPF4B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.444000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.466600E-01
Normal-vs-Stage2
3.478200E-01
Normal-vs-Stage3
2.134800E-01
Normal-vs-Stage4
6.381400E-01
Stage1-vs-Stage2
2.288200E-01
Stage1-vs-Stage3
1.324640E-01
Stage1-vs-Stage4
6.609600E-01
Stage2-vs-Stage3
1.637980E-01
Stage2-vs-Stage4
8.729700E-02
Stage3-vs-Stage4
1.544030E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.441600E-01
Normal-vs-AfricanAmerican
4.026600E-01
Normal-vs-Asian
5.461700E-02
Caucasian-vs-AfricanAmerican
2.359200E-01
Caucasian-vs-Asian
2.958600E-01
AfricanAmerican-vs-Asian
1.614010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.376000E-01
Normal-vs-Female
3.514400E-02
Male-vs-Female
6.453400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.312800E-01
Normal-vs-Age(41-60Yrs)
6.465900E-02
Normal-vs-Age(61-80Yrs)
3.162600E-01
Normal-vs-Age(81-100Yrs)
1.433960E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.353400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.168400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.525000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.055700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.672200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.235000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.119000E-01
Normal-vs-Daily Drinker
2.449800E-01
Normal-vs-Weekly Drinker
3.029200E-01
Normal-vs-Occasional Drinker
5.144400E-02
Normal-vs-Social Drinker
1.423160E-01
Non Drinker-vs-Daily Drinker
1.555560E-01
Non Drinker-vs-Weekly Drinker
8.439000E-01
Non Drinker-vs-Occasional Drinker
5.930400E-01
Non Drinker-vs-Social Drinker
2.290800E-01
Daily Drinker-vs-Weekly Drinker
3.159200E-01
Daily Drinker-vs-Occasional Drinker
8.163600E-02
Daily Drinker-vs-Social Drinker
2.614100E-02
Weekly Drinker-vs-Occasional Drinker
5.401200E-01
Weekly Drinker-vs-Social Drinker
2.579000E-01
Occasional Drinker-vs-Social Drinker
5.318600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.968000E-02
Normal-vs-Grade 2
2.606200E-02
Normal-vs-Grade 3
1.993690E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.651400E-01
Grade 1-vs-Grade 3
4.306600E-01
Grade 1-vs-Grade 4
8.968000E-02
Grade 2-vs-Grade 3
4.500200E-01
Grade 2-vs-Grade 4
2.606200E-02
Grade 3-vs-Grade 4
1.993690E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.924600E-01
Normal-vs-NonDiabetic
3.091000E-01
Diabetic-vs-NonDiabetic
6.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.726000E-01
Normal-vs-NoPancreatitis
3.130000E-01
Pancreatitis-vs-NoPancreatitis
4.449400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.175800E-02
Normal-vs-N1
3.447800E-01
N0-vs-N1
7.676000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.610000E-01
Normal-vs-TP53-NonMutant
1.647620E-01
TP53-Mutant-vs-TP53-NonMutant
1.375610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
